View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
August 3, 2022

Magazine: How noninvasive NASH tests can move the needle

In this issue, we take a look at noninvasive tests in NASH, the future of ALS devices, monkeypox testing kits, and more.

By Alvaro Arjona

In this month’s issue, we look into the future of two indications with high unmet need – amyotrophic lateral sclerosis (ALS) and nonalcoholic steatohepatitis (NASH)– through the lens of medical tech advances that aim to improve patients’ quality of life or accelerate the development of therapies via a less cumbersome method of diagnosis.

On the occasion of World IVF day, in another forward-looking analysis, we examine the assisted reproductive tech sector and the investment opportunities it presents.

Also in this issue, we dive into the latest trends in medical applications of nanotechnology.

Elsewhere, coinciding with the World Health Organization’s recent declaration of monkeypox as a global health emergency, we discuss new tests in development and how increased surveillance may drive this market. In a comment piece, Matt Barnes shares his vision for an IT network architecture fit for the NHS’ digital journey.

Read the latest issue of Medical Technology for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a issue is available.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network